|
WEDNESDAY, APRIL 23
TECH EXPO • 8:30 am - 12 pm
Explore available next generation screening platforms as presented by sequencing leaders. An unparalleled opportunity to compare and contrast these next generation sequencing platforms to best suit your research needs.
Sponsored Seminars Hosted by:
454/Roche
Title and Speaker to be Announced
True Single Molecule Sequencing: Current Research and Our Path to the $1000 Genome
Patrice M. Milos, Ph.D., Vice President and Chief Scientific Officer, Helicos
Helicos has developed a novel genetic analysis platform to efficiently and accurately determine the direct sequence of individual DNA molecules. Simplicity in sample preparation, development of novel surfaces, chemistry to enable incorporation of single nucleotides into DNA strands and finally the visualization of fluorophore addition to monitor real time sequencing by synthesis has been achieved. This platform will provide the opportunity for researchers to interrogate the genome on a new scale and provides a path to sequence individual genomes at a cost to make integration of genome knowledge and healthcare possible. To demonstrate the current power of the HelicosTM platform we will discuss the use of the True Single Molecule Sequencing Technology (tSMSTM) for candidate gene resequencing, RNA measurements and miRNA analyses.
Illuminating the Genome
Abizar Lakdawalla, Ph.D., Senior Product Manager, Sequencing Applications, Illumina
The Illumina Genome Analyzer, based on the Solexa massively parallel sequencing-by-synthesis technology, is being utilized for a broad set of functional genomics applications including chromosomal re-arrangements to single nucleotide variations, variation in DNA methylation, whole transcriptiome analysis, small RNA analysis, digital gene expression, DNA-protein, and DNA-RNA interaction analysis. Details on the current state of the technology as well as a summary of chromosomal resequencing studies, whole genome epigenetic changes, tissue-specific mRNA splice variants and 5-UTRs, microRNAs and DNA-protein interaction studies will be presented.
Challenge Team Discussion
Host: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World |